Since 2011, the Master 2 Microfluidics program has trained researchers who go on to shape the field — from fundamental soft matter to organ-on-chip systems, liquid biopsy diagnostics, and industrial innovation. The profiles below reflect career trajectories from our first cohorts (2018–2020), based on publicly available data.

Program in numbers — 2018 to 2024

Across seven cohorts (2018–2024), 74 students have enrolled in the program.

   
75% pursue a PhD directly after graduation 47% of students are female
31% are international students (20+ nationalities) 93% graduation rate

Where are they now?

Alumni pursue diverse careers in academia, industry, and deep-tech innovation — in France and internationally.

Claire N. — 2018 cohort

R&D Engineer, Michelin · Clermont-Ferrand, France

Claire completed her PhD at ESPCI Paris (2019–2023) on surfactant-free emulsions. Her doctoral work led to a publication in Science (2024), covered by Le Monde.
She now leads composite materials development at Michelin, managing projects across Europe, Asia, and the Americas.

Thomas M. — 2019 cohort

Automation Chemist, Chemspeed Technologies (Bruker) · Basel, Switzerland

Thomas completed a five-year PhD at ETH Zürich in the deMello Group (2020–2025), using droplet microfluidics to accelerate the discovery of single-atom heterogeneous catalysts — achieving up to 100-fold faster syntheses. He joined Chemspeed (Bruker) in early 2026 to develop automated chemistry platforms for R&D and quality control in academia and industry.

Isabelle E. — 2019 cohort

Postdoctoral Researcher, University of Amsterdam · Netherlands

After a PhD in physics at the École Normale Supérieure, Isabelle joined the University of Amsterdam as a postdoctoral researcher in September 2024. Her current work focuses on photosynthetic organisms and chiral active matter — at the interface of biological physics and non-equilibrium soft matter.

Henar M. — 2020 cohort

PhD candidate, KTH Royal Institute of Technology · Stockholm, Sweden

Henar is pursuing a PhD in biomicrofluidics and microsystems at KTH (November 2021–March 2026). She spent six months as a visiting researcher at Harvard Medical School (October 2024–April 2025) — a trajectory that illustrates how the M2 opens doors to top European and international research programmes.

Ana M. — 2020 cohort

Associate Consultant, Strategy& (PwC) · Zurich, Switzerland

Ana completed her PhD at ENS Paris-Saclay (2021–2025), developing a microfluidic liver-on-chip platform for studying drug-induced hepatotoxicity, coordinating five laboratories across academic, clinical, and industrial environments. After a short postdoctoral position at ENS Paris-Saclay, she transitioned to strategy consulting at Strategy& in 2026.

Anirban J. — 2020 cohort

R&D Engineer, TreeFrog Therapeutics · Bordeaux, France

Anirban joined TreeFrog Therapeutics — a leading cell therapy company — directly after the M2, and has worked there for over five years on scaling cell encapsulation systems using millifluidics and soft matter rheology. He is simultaneously pursuing a PhD at the Université de Bordeaux and Institut d’Optique (2023–2026) on the mechanics of 3D iPSC epiblast models using opto-fluidic tools.

Names are anonymised to first name and initial. Profiles are based on publicly available LinkedIn data, verified in 2025–2026.